Table 1.
iStent inject (44 eyes) | |
---|---|
Gender M/F | 23/21 |
Age (years) Mean ± SD (range) |
71.3 ± 10.5 (40–88) |
Race | 100% Caucasian |
C:D ratio Mean ± SD (range) |
0.8 ± 0.1 (0.5–1.0) |
VF MD (dB) Mean ± SD (range) |
– 6.4 ± 6.9 dB (− 24.4 to − 0.3) |
Type of glaucoma n (%) | |
POAG PXG |
38 (86.4%) 4 (9.1%) |
Appositional narrow anglea | 1 (2.3%) |
Secondary (neovascular) | 1 (2.3%) |
Mean medicated IOP (mmHg); mean ± SD | 25.3 ± 6.0 mmHg |
Medicated IOP level (mmHg) n (%) | |
≤ 15 mmHg | 1 (2.3%) |
≤ 18 mmHg | 4 (9.1%) |
Mean # medications; mean ± SD | 2.98 ± 0.88 |
Eyes with prior glaucoma surgery n (%) | 22 (50.0%) |
Prior glaucoma surgeries, n = 35 surgeriesb | |
Trabeculectomy | 13 |
CPC | 14 |
ALT/SLT | 3 |
Laser iridotomy | 2 |
Single iStent | 1 |
XEN implantation | 2 |
Eyes on 3–5 preoperative medications, n (%) | 33 (75%) |
SD standard deviation, C:D cup to disc, VF MD visual field mean deviation, CPC cyclophotocoagulation, ALT argon laser trabeculoplasty, SLT selective laser trabeculoplasty
aEyes had open-angle configuration in the area of iStent inject implantation
bEyes could have more than one surgery (there were 35 surgeries in 22 eyes)